Data Sharing Policy

Media Publikasi Promosi Kesehatan Indonesia

Media Publikasi Promosi Kesehatan Indonesia (MPPKI) supports responsible research-data management and the appropriate sharing of data that underpin published findings. Transparent data practices strengthen research integrity, verification, reproducibility, scholarly collaboration, secondary analysis, and public confidence in scientific communication.

Data sharing must be conducted ethically, legally, securely, and consistently with participant consent, research ethics approval, privacy and confidentiality requirements, intellectual-property rights, institutional policies, contractual obligations, funding requirements, and applicable laws.

1. Scope of the Policy

This policy applies to research data and supporting materials associated with manuscripts submitted to or published by MPPKI. Depending on the study design, these materials may include:

• quantitative or qualitative datasets;
• de-identified individual participant data;
• data dictionaries, codebooks, and variable descriptions;
• questionnaires, survey instruments, interview guides, and observation forms;
• study protocols and statistical analysis plans;
• analytical code, scripts, syntax, algorithms, and computational workflows;
• tables, figures, images, audio, video, or other research records;
• documentation required to understand, verify, or reproduce the reported findings.

2. Author Responsibility and Access to Data

Authors are responsible for the authenticity, accuracy, integrity, documentation, security, retention, and lawful use of the data reported in their manuscript.

All authors should have sufficient access to the data supporting the study results to review the accuracy of the manuscript and accept accountability for their respective contributions. At least one author must be able to explain the origin, management, analysis, and interpretation of the primary data.

• Reported findings must be supported by authentic and appropriately maintained data.
• Data must not be fabricated, falsified, selectively altered, or misleadingly presented.
• Appropriate ethical approval and participant consent must be obtained where required.
• Personal, confidential, and sensitive information must be adequately protected.
• Third-party data must be used only within the permissions granted by the data owner.
• The corresponding author must be able to respond to reasonable editorial questions concerning the data.

3. Data Availability Statement

Every Original Research Article must include a clearly identified Data Availability Statement. The statement must accurately explain whether the data supporting the findings are available and how they may be accessed.

A Review Article should also include a Data Availability Statement when the review involves a new dataset, independently extracted study-level data, coded evidence, meta-analysis files, analytical scripts, or other materials generated as part of the review.

The statement should specify, where applicable:

• which data and supporting materials are available;
• where the data are stored;
• the repository name and persistent identifier;
• whether access is open, restricted, controlled, or available upon reasonable request;
• the eligibility and conditions for access;
• when the data will become available and for how long;
• the permitted purposes or types of analysis;
• the reason data cannot be shared, where applicable.

4. Data Availability Statement Templates

5. Data Repositories

Where ethically and legally appropriate, authors are encouraged to deposit research data in an established disciplinary, institutional, national, or general-purpose repository.

A suitable repository should preferably:

• provide a persistent identifier, such as a DOI;
• support long-term preservation and stable access;
• provide clear access, reuse, and licensing conditions;
• permit appropriate metadata and supporting documentation;
• support embargoed or controlled access when necessary;
• apply appropriate privacy and security safeguards.

Personal websites, temporary file-transfer services, private cloud folders, and unstable download links should not be used as the primary long-term location for research data. MPPKI does not serve as a general research-data repository.

6. Sensitive, Personal, and Confidential Data

Authors must not publicly disclose data that could directly or indirectly identify research participants unless explicit consent and lawful authorization for such disclosure have been obtained.

Sensitive or potentially identifiable data may include:

• names, addresses, contact details, or identification numbers;
• medical records, clinical information, or health histories;
• genetic, genomic, biometric, or biological information;
• photographs, audio recordings, videos, or identifiable media;
• sensitive demographic, social, behavioral, occupational, or geographic information;
• information concerning children or vulnerable individuals and communities;
• confidential institutional, governmental, cultural, or proprietary information.

De-identification or anonymization must be appropriate to the nature of the data and the foreseeable risk of re-identification. Removing names or direct identifiers alone may not be sufficient.

7. Ethical, Legal, and Contractual Restrictions

MPPKI recognizes that unrestricted public sharing may not be appropriate for every study. Legitimate restrictions may arise from:

• limitations in participant consent;
• ethics committee or institutional review requirements;
• privacy and personal-data protection obligations;
• risk of participant, family, group, or community identification;
• cultural, community, or security considerations;
• third-party ownership, licensing, or database conditions;
• commercial confidentiality or intellectual-property protection;
• institutional, governmental, funding, or contractual restrictions.

Authors must not use confidentiality, privacy, ownership, or ethical approval as a generic justification for withholding data. The restriction and its basis must be described accurately and specifically in the Data Availability Statement.

8. Clinical Trial Data Sharing

Manuscripts reporting the results of clinical trials must include a data-sharing statement consistent with the registered trial information and applicable clinical-trial reporting requirements.

The statement must indicate:

• whether de-identified individual participant data will be shared;
• which data will be shared;
• whether a data dictionary will be available;
• whether the protocol, statistical analysis plan, or analytical code will be available;
• when the data will become available and for how long;
• who may obtain access;
• the permitted purposes and types of analysis;
• the criteria and mechanism for requesting access.

Where a data-sharing plan has been included in a clinical-trial registry, the published statement must be consistent with that plan. Any material change should be explained and updated in the registry where applicable.

9. Third-Party and Secondary Data

Authors using data created, controlled, or owned by another individual, institution, repository, government body, community, or commercial organization must comply with all applicable access and reuse conditions.

• Obtain all necessary permissions, licenses, or approvals.
• Acknowledge and cite the original data source.
• Provide a persistent identifier where available.
• Describe any restrictions on redistribution.
• Comply with the applicable data-use agreement.
• Explain how the submitted analysis differs from previous analyses of the same data.

Use of another person’s data does not automatically qualify that person or the data custodian for authorship. Authorship must comply with the MPPKI Authorship and Contributorship Policy.

10. Requests for Data

When authors state that data are available upon reasonable request, they should respond to legitimate requests professionally and within a reasonable period.

A request may be evaluated according to:

• the identity and institutional affiliation of the requester;
• the scientific purpose and proposed analysis;
• the qualifications of the research team;
• ethical and legal authorization;
• participant privacy and confidentiality risks;
• the terms of participant consent and original ethics approval;
• the need for a data-use or confidentiality agreement;
• the resources reasonably required to prepare and transfer the data.

Data access must not be denied arbitrarily. Where a request is declined, the reason should be legitimate, documented, and consistent with the published Data Availability Statement.

11. Data Citation and Recognition

Research datasets used in a manuscript should be cited appropriately when a formal data citation or persistent identifier is available.

Authors conducting secondary analyses must appropriately recognize the individuals, communities, institutions, or organizations responsible for generating, curating, preserving, and sharing the original data.

Access to or management of shared data does not automatically justify authorship. All authors must satisfy the requirements described in the journal’s Authorship and Contributorship Policy.

12. Editorial Access to Supporting Data

During submission, peer review, investigation, or post-publication assessment, the editor may request access to supporting data, analytical files, source documentation, ethical approvals, consent documentation, or other relevant records when necessary to evaluate the accuracy and integrity of the manuscript.

Materials provided for editorial assessment will be handled confidentially and used only for legitimate editorial, peer-review, or research-integrity purposes.

Failure to provide requested data or documentation without an adequate explanation may delay the editorial process and may affect the journal’s decision.

13. Data Retention and Documentation

Authors should retain research data and relevant documentation for a period consistent with institutional, funding, ethical, legal, contractual, and disciplinary requirements.

14. Data Licensing and Article Licensing

MPPKI articles are published under the journal’s applicable open-access license, currently Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

The license applied to a published article does not automatically determine the ownership, access conditions, or permitted reuse of the underlying research data.

Authors depositing data in a repository should select an appropriate data license and must ensure that they have the legal authority to apply that license. Third-party, sensitive, and controlled-access data may be governed by different conditions.

15. Confidentiality During Peer Review

Reviewers and editors must treat unpublished datasets, supplementary files, and supporting documentation as confidential materials.

• Confidential data must not be copied, retained, distributed, or disclosed without authorization.
• Unpublished data must not be used for personal, institutional, or commercial benefit.
• Reviewers and editors must not use the data in their own research without prior authorization.
• Confidential manuscript data must not be uploaded to external AI systems or third-party services unless explicitly authorized by the journal and adequate confidentiality safeguards are in place.

These requirements should be read together with the MPPKI Peer Review Process and Artificial Intelligence Usage Policy.

16. Non-Compliance and Misrepresentation

The following may constitute a breach of publication ethics:

• fabrication, falsification, destruction, or unauthorized alteration of data;
• misrepresentation of data availability;
• refusal to provide supporting data without adequate justification;
• breach of participant privacy or confidentiality;
• unauthorized use or redistribution of third-party data;
• violation of participant consent, ethics approval, or a data-use agreement;
• submission of fabricated or unreliable AI-generated data;
• failure to disclose material restrictions affecting data access or interpretation.

Depending on the nature, seriousness, evidence, and stage of the case, MPPKI may:

• request clarification or additional documentation;
• require correction of the manuscript or Data Availability Statement;
• suspend the editorial process;
• reject or withdraw the manuscript from consideration;
• publish a correction, expression of concern, or retraction;
• contact the authors’ institutions, funders, ethics committees, or data custodians;
• take other proportionate action under the journal’s Publication Ethics policies.

17. Relationship with Other Journal Policies

This policy should be read together with the following MPPKI policies and guidelines: